Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $812.07 billion, total revenue of $173 billion and a weighted average PE ratio of 45.26.
Market Cap
812.07B
Revenue
173B
Profits
17.94B
PE Ratio
45.26
Profit Margin
10.37%
Dividend Yield
0.20%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 218.95B | 1.13% | 619,218 | 46.34B |
| 2 | DHR | Danaher Corporation | 141.15B | -0.91% | 1,407,166 | 25.11B |
| 3 | NTRA | Natera, Inc. | 45.15B | -0.29% | 809,823 | 2.71B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 43.90B | 2.05% | 267,339 | 4.55B |
| 5 | A | Agilent Technologies, Inc. | 42.12B | 0.46% | 814,330 | 7.23B |
| 6 | IQV | IQVIA Holdings Inc. | 39.88B | 0.44% | 590,713 | 16.98B |
| 7 | WAT | Waters Corporation | 39.65B | -1.03% | 427,153 | 4.64B |
| 8 | ILMN | Illumina, Inc. | 28.42B | -2.56% | 827,226 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 28.07B | -1.18% | 73,320 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 26.36B | 0.52% | 308,654 | 14.35B |
| 11 | DGX | Quest Diagnostics Incorporated | 26.10B | 0.41% | 331,247 | 11.56B |
| 12 | GH | Guardant Health, Inc. | 21.51B | -0.84% | 871,647 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.51B | -0.92% | 90,753 | 2.78B |
| 14 | CRL | Charles River Laboratories International, Inc. | 13.39B | -2.15% | 452,605 | 4.00B |
| 15 | ICLR | ICON Public Limited Company | 13.07B | -0.04% | 313,719 | 8.29B |
| 16 | RVTY | Revvity, Inc. | 12.82B | -1.11% | 324,236 | 2.91B |
| 17 | QGEN | Qiagen N.V. | 8.82B | 0.14% | 1,764,170 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 7.29B | -6.55% | 907,552 | 431.80M |
| 19 | RDNT | RadNet, Inc. | 5.82B | -2.52% | 227,974 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.28B | -1.65% | 1,479,029 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.22B | -4.78% | 392,015 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 3.92B | -0.81% | 1,156,780 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.29B | -2.78% | 625,107 | 561.90M |
| 24 | GRAL | GRAIL, Inc. | 3.12B | -0.23% | 315,527 | 165.26M |
| 25 | CDNA | CareDx, Inc. | 2.35B | -1.94% | 367,346 | 458.09M |
| 26 | WGS | GeneDx Holdings Corp. | 2.27B | -1.69% | 262,483 | 454.43M |
| 27 | NEO | NeoGenomics, Inc. | 2.05B | -1.49% | 557,811 | 766.30M |
| 28 | FRNM | Freenome, Inc. | 1.52B | 3.35% | 1,225,250 | 34.24M |
| 29 | PSNL | Personalis, Inc. | 1.49B | 0.36% | 500,448 | 69.67M |
| 30 | OPK | OPKO Health, Inc. | 1.02B | - | 1,084,862 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 887.77M | -2.97% | 254,416 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 510.13M | -0.64% | 93,503 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 274.04M | -6.07% | 1,330,742 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 239.72M | -2.28% | 28,541 | 102.94M |
| 35 | XGN | Exagen Inc. | 158.43M | -2.39% | 174,343 | 71.12M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 139.73M | - | 254,266 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 121.90M | -1.36% | 430,727 | 537.08K |
| 38 | BNR | Burning Rock Biotech Limited | 105.46M | 9.89% | 10,307 | 74.58M |
| 39 | PRPO | Precipio, Inc. | 43.47M | 1.76% | 325,133 | 27.20M |
| 40 | MDXH | MDxHealth SA | 40.14M | -8.66% | 2,497,639 | 114.02M |
| 41 | ADVB | Advanced Biomed Inc. | 14.67M | 7.90% | 178,548 | - |
| 42 | MBAI | Check-Cap Ltd. | 9.06M | 2.24% | 12,078 | - |
| 43 | XWEL | XWELL, Inc. | 7.94M | 1.08% | 17,367 | 28.28M |
| 44 | NDRA | ENDRA Life Sciences Inc. | 5.72M | 0.22% | 2,105 | - |
| 45 | ISPC | iSpecimen Inc. | 5.62M | 7.44% | 54,532 | 466.30K |
| 46 | BIAF | bioAffinity Technologies, Inc. | 3.76M | 18.60% | 166,236,071 | 5.90M |